Professional Documents
Culture Documents
Autoimmunity and Disorders
Autoimmunity and Disorders
Autoimmune Disorders
INJAMAM UL HOSSAIN
MSc Medical Biochemistry
Final Year
20/06/2023 1
Contents:
Autoimmunity
20/06/2023 2
Autoimmunity:
• Autoimmunity is defined as an immune response against self
(autologous) antigens
Reference: Basic Immunology Functions and disorders of immune system; Abul.K Abbas,
Andrew H. Lichtman; 3rd ed.
20/06/2023 3
Mechanism of
Autoimmunity:
Reference: Kuby
Immunology; 7th
Edition
20/06/2023 6
Mechanisms by
which
microbes
promote
autoimmunity
20/06/2023 8
Exposure to carcinogens or infectious agents that favor DNA
damage or polyclonal activation can potentially interfere with
this regulation and/or lead to the expansion and survival of rare
T- or B-cell clones with autoimmune potential
20/06/2023 9
The Role of Genes in Susceptibility to Autoimmunity:
• Certain alleles within the MHC have been linked to several
different autoimmune disorders
• Example:
Ankylosing spondylitis,
20/06/2023 13
Autoimmunity due to release of
sequestered antigens:
• Tissue antigens that are not expressed in the thymus will not
engage with developing T cells and will thus not induce self-
tolerance
Organ
Systemic
Specific
20/06/2023 22
Organ specific autoimmune diseases:
Hashimoto’s Thyroiditis
Grave’s Disease
Myasthenia Gravis
20/06/2023 23
Hashimoto’s Thyroiditis:
• In this disease individuals produce autoantibodies against various
proteins such as, thyroglobulin and thyroid peroxidase
20/06/2023 26
Type 1 Diabetes Mellitus (T1DM):
• Here autoantibody develops against β-cells of pancreas
20/06/2023
Reference: Kuby Immunology; 7th Edition 27
Diagnosis:
Clinically:
Age: <20years
Polyuria
Polyphagia
Polydepsia
Laboratory diagnosis:
FBS: ≥126mg/dl
PPBS: ≥200mg/dl
HBA1c: ≥6.5%
Serum Insulin: Low
Serum C-peptide: Low
Reference:
20/06/2023
Harrison’s Principles of Internal Medicine; 19th Edition 28
Myasthenia Gravis:
• Myasthenia gravis (MG) is an autoimmune disease caused by
antibodies against the acetylcholine receptor (AChR), muscle-
specific kinase (MuSK) or other AChR-related proteins such as
lipoprotein-receptor-related protein 4 (LRP4) in the postsynaptic
muscle membrane
20/06/2023 30
20/06/2023
Reference: Kuby Immunology; 7th Edition 31
Reference: Nils Erik Gilhus et al; Myasthenia gravis; NAture RevIews | DISEASE PrIMErS | Article citation ID: (2019) 5:30
20/06/2023 32
Reference: Nils Erik Gilhus et al; Myasthenia gravis; NAture RevIews | DISEASE PrIMErS | Article citation ID: (2019) 5:30
20/06/2023 33
20/06/2023 34
Diagnosis of
Myasthenia
Gravis:
Reference: Nils Erik Gilhus et al; Myasthenia gravis; Nature reviews | DISEASE primers | Article citation ID: (2019) 5:30
35
20/06/2023
Management
of Chronic
Myasthenia
gravis:
Reference: Nils Erik Gilhus et al; Myasthenia gravis; Nature reviews | DISEASE primers | Article citation ID: (2019) 5:30
20/06/2023 36
Management of Chronic
Myasthenia gravis:
Reference: Nils Erik Gilhus et al; Myasthenia gravis; Nature Review; Disease primer | Article citation ID: (2019) 5:30
20/06/2023 37
Systemic autoimmune diseases:
Ankylosing spondylitis
Rheumatoid arthritis Scleroderma
20/06/2023 39
Rheumatoid arthritis:
• These IgM-IgG complexes can activate the complement
cascade, resulting in a type III hypersensitivity reaction, which
leads to chronic inflammation of the joints
20/06/2023 40
Pathophysiology of
Rheumatoid arthritis:
20/06/2023 42
Diagnosis of Rheumatoid arthritis:
Laboratory Investigations:
C-reactive protein
Erythrocyte Sedimentation rate (ESR)
Reference:
20/06/2023
Harrison’s Principles of Internal Medicine; 19th Edition 43
Diagnosis of Rheumatoid arthritis:
Synovial Fluid Analysis:
• White blood cell count (WBCs): 5000-50,000 WBC/μl
• Sterile, turbid synovial fluid with decreased viscosity, poor
mucin clot formation
Reference:
20/06/2023
Harrison’s Principles of Internal Medicine; 19th Edition 44
Diagnosis of Rheumatoid arthritis:
Imaging Techniques:
X-ray
MRI
PET Scan
CT Scan
DEXA Scan
Reference:
20/06/2023
Harrison’s Principles of Internal Medicine; 19th Edition 45
Management of Rheumatoid arthritis:
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Corticosteroids
Pathophysiology: